News

Emblation has moved into its stunning new £4m office in Stirling, ushering in the start of a new era. We have invested heavily in our new HQ Emblation House – which boasts a sauna, gym, chillout area and a 90-person auditorium.

We at Emblation have partnered with one of the top aesthetic equipment distributors in Singapore to expand the global reach of our innovative microwave device.

The Emblation team is undertaking a rigorous clinical trial which could transform the fortunes of our microwave treatments in the US.

Technology pioneered by our Emblation team has featured in promising new research which could deliver less painful and more effective treatment for cervical cancer patients.

Emblation has reached a milestone after completing 200,000 treatments with our innovative microwave device for treating common skin problems.

Our exciting skin treatment device has made its first crossover breakthrough into an aesthetic clinic, after taking the podiatry world by storm.

IDE approval was received in April 2022 from the FDA for the SWIFT multi-centre, open, randomized, controlled, parallel-group, blind-assessed trial.